OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Agnes Shanley is senior editor of BioPharm International.
March 02, 2021
The COVID-19 pandemic is pushing more companies to adopt just-in-time practices, but success demands careful upfront risk assessment and planning.
June 01, 2020
The COVID-19 pandemic has led to increased demand for direct-to-patient shipments, challenging cold-chain specialists to become more agile and to strengthen their global distribution networks.
February 11, 2020
As politicians focus on drug cost reduction, biopharmaceutical companies in the US are moving to states with lower taxes, and relocating some facilities that had been offshore.
August 01, 2019
Now that the first genetically modified cell therapies are being manufactured, the industry must move beyond “whatever works” to meet growing demand.
July 02, 2019
The means to continually improving and enabling the use of artificial intelligence in manufacturing lies in the ability to make data accessible across functions and to contract partners.
March 07, 2019
Often, transferring an analytical method from R&D to quality control fails; success depends on determining where “the best” and “the most reliable” intersect.